Advertisement
Research Article| Volume 357, ISSUE 1-2, P178-182, October 15, 2015

Download started.

Ok

Differentiating progressive supranuclear palsy from Parkinson's disease by MRI-based dynamic cerebrospinal fluid flow

  • Yusuke Fukui
    Affiliations
    Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikatacho, Kitaku, Okayama 700-8558, Japan
    Search for articles by this author
  • Nozomi Hishikawa
    Affiliations
    Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikatacho, Kitaku, Okayama 700-8558, Japan
    Search for articles by this author
  • Kota Sato
    Affiliations
    Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikatacho, Kitaku, Okayama 700-8558, Japan
    Search for articles by this author
  • Taijun Yunoki
    Affiliations
    Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikatacho, Kitaku, Okayama 700-8558, Japan
    Search for articles by this author
  • Syoichiro Kono
    Affiliations
    Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikatacho, Kitaku, Okayama 700-8558, Japan
    Search for articles by this author
  • Kosuke Matsuzono
    Affiliations
    Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikatacho, Kitaku, Okayama 700-8558, Japan
    Search for articles by this author
  • Yumiko Nakano
    Affiliations
    Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikatacho, Kitaku, Okayama 700-8558, Japan
    Search for articles by this author
  • Yasuyuki Ohta
    Affiliations
    Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikatacho, Kitaku, Okayama 700-8558, Japan
    Search for articles by this author
  • Toru Yamashita
    Affiliations
    Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikatacho, Kitaku, Okayama 700-8558, Japan
    Search for articles by this author
  • Kentaro Deguchi
    Affiliations
    Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikatacho, Kitaku, Okayama 700-8558, Japan
    Search for articles by this author
  • Koji Abe
    Correspondence
    Corresponding author at: Department of Neurology, Okayama University Graduate School of Medicine, Dentistry and Pharmacy, 2-5-1 Shikata-cho, Okayama 700-8558, Japan.
    Affiliations
    Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikatacho, Kitaku, Okayama 700-8558, Japan
    Search for articles by this author

      Highlights

      • The purpose was to clarify difference between PSP and PD in the dynamic CSF flow.
      • CSF flow was calculated by 15 images in MRI that was taken through a cardiac cycle.
      • The width of the CSF velocity showed significant declines in PSP than PD patients.
      • MRI measurement showed a good discrimination on the area of the midbrain aqueduct.

      Abstract

      Objective

      The purpose of this study was to clarify the difference between PSP and PD from the viewpoint of dynamic cerebrospinal fluid (CSF) flow focusing on the midbrain aqueduct.

      Methods

      Thirty-three PD patients (mean age 69.2 ± 7.9) and 35 PSP patients (mean age 70.5 ± 6.6) were included in this study. CSF flow was calculated by 15 images in an equidistant magnetic resonance imaging (MRI) sequence that was taken throughout a cardiac cycle.

      Results

      Absolute values of the velocity (time points of 2–6 and 12–15, *p < 0.05), and the width of the CSF velocity (Vheight) (PSP, 5.1 ± 2.3 cm/s; PD, 6.0 ± 1.6 cm/s, p < 0.05) effectively discriminated PSP from PD patients. On the other hand, conventional MRI measurements discriminated well the midbrain aqueduct area (Area) (PSP, 7.7 ± 2.6 mm2; PD, 5.4 ± 1.8 mm2, p < 0.01). Two cutoff value lines (Vheight: 4.75, Area: 5.77) of the ROC curve analysis established two areas for discriminating PSP from PD.

      Conclusion

      In the present dynamic CSF flow study, it was newly found that mean velocity of each time point and Vheight showed a more significant decline in PSP than in PD patients, providing a sensitive biomarker for differentiating them. The combination of Vheight and Area could further discriminate PSP from PD patients.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Steele J.C.
        • Richardson J.C.
        • Olszewski J.
        Progressive Supranuclear Palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia.
        Arch. Neurol. 1964; 10: 333-359
        • Albert M.L.
        • Feldman R.G.
        • Willis A.L.
        The ‘subcortical dementia’ of progressive supranuclear palsy.
        J. Neurol. Neurosurg. Psychiatry. 1974; 37: 121-130
        • Liao K.
        • Wagner J.
        • Joshi A.
        • Estrovich I.
        • Walker M.F.
        • Strupp M.
        • et al.
        Why do patients with PSP fall? Evidence for abnormal otolith responses.
        Neurology. 2008; 70: 802-809
        • Tolosa E.
        • Wenning G.
        • Poewe W.
        The diagnosis of Parkinson's disease.
        Lancet Neurol. 2006; 5: 75-86
        • Litvan I.
        • Agid Y.
        • Calne D.
        • Campbell G.
        • Dubois B.
        • Duvoisin R.C.
        • et al.
        Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele–Richardson–Olszewski syndrome): report of the NINDS–SPSP international workshop.
        Neurology. 1996; 47: 1-9
        • Litvan I.
        • Campbell G.
        • Mangone C.A.
        • Verny M.
        • McKee A.
        • Chaudhuri K.R.
        • et al.
        Which clinical features differentiate progressive supranuclear palsy (Steele–Richardson–Olszewski syndrome) from related disorders? A clinicopathological study.
        Brain. 1997; 120: 65-74
        • Warmuth-Metz M.
        • Naumann M.
        • Csoti I.
        • Solymosi L.
        Measurement of the midbrain diameter on routine magnetic resonance imaging: a simple and accurate method of differentiating between Parkinson disease and progressive supranuclear palsy.
        Arch. Neurol. 2001; 58: 1076-1079
        • Brenneis C.
        • Seppi K.
        • Schocke M.
        • Benke T.
        • Wenning G.K.
        • Poewe W.
        Voxel based morphometry reveals a distinct pattern of frontal atrophy in progressive supranuclear palsy.
        J. Neurol. Neurosurg. Psychiatry. 2004; 75: 246-249
        • Watabe N.
        • Tominaga T.
        • Shimizu H.
        • Koshu K.
        • Yoshimoto T.
        Quantitative analysis of cerebrospinal fluid flow in patients with cervical spondylosis using cine phase-contrast magnetic resonance imaging.
        Neurosurgery. 1999; 44: 779-784
        • Hofmann E.
        • Warmuth-Metz M.
        • Bendszus M.
        • Solymosi L.
        Phase-contrast MR imaging of the cervical CSF and spinal cord: volumetric motion analysis in patients with Chiari I malformation.
        AJNR Am. J. Neuroradiol. 2000; 21: 151-158
        • Tominaga T.
        • Watabe N.
        • Takahashi T.
        • Shimizu H.
        • Yoshimoto T.
        Quantitative assessment of surgical decompression of the cervical spine with cine phase contrast magnetic resonance imaging.
        Neurosurgery. 2002; 50 (discussion 6): 791-795
        • Sundstrom P.
        • Wahlin A.
        • Ambarki K.
        • Birgander R.
        • Eklund A.
        • Malm J.
        Venous and cerebrospinal fluid flow in multiple sclerosis: a case-control study.
        Ann. Neurol. 2010; 68: 255-259
        • Sato K.
        • Morimoto N.
        • Matsuura T.
        • Ohta Y.
        • Tsunoda M.
        • Ikeda Y.
        • et al.
        CSF flow dynamics in motor neuron disease.
        Neurol. Res. 2012; 34: 512-517
        • Hughes A.J.
        • Daniel S.E.
        • Kilford L.
        • Lees A.J.
        Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.
        J. Neurol. Neurosurg. Psychiatry. 1992; 55: 181-184
        • Righini A.
        • Antonini A.
        • De Notaris R.
        • Bianchini E.
        • Meucci N.
        • Sacilotto G.
        • et al.
        MR imaging of the superior profile of the midbrain: differential diagnosis between progressive supranuclear palsy and Parkinson disease.
        AJNR Am. J. Neuroradiol. 2004; 25: 927-932
        • Seppi K.
        • Poewe W.
        Brain magnetic resonance imaging techniques in the diagnosis of parkinsonian syndromes.
        Neuroimaging Clin. N. Am. 2010; 20: 29-55
        • Tsukamoto K.
        • Matsusue E.
        • Kanasaki Y.
        • Kakite S.
        • Fujii S.
        • Kaminou T.
        • et al.
        Significance of apparent diffusion coefficient measurement for the differential diagnosis of multiple system atrophy, progressive supranuclear palsy, and Parkinson's disease: evaluation by 3.0-T MR imaging.
        Neuroradiology. 2012; 54: 947-955
        • Shoji M.
        • Matsubara E.
        • Murakami T.
        • Manabe Y.
        • Abe K.
        • Kanai M.
        • et al.
        Cerebrospinal fluid tau in dementia disorders: a large scale multicenter study by a Japanese study group.
        Neurobiol. Aging. 2002; 23: 363-370
        • Constantinescu R.
        • Zetterberg H.
        • Holmberg B.
        • Rosengren L.
        Levels of brain related proteins in cerebrospinal fluid: an aid in the differential diagnosis of parkinsonian disorders.
        Parkinsonism Relat. Disord. 2009; 15: 205-212
        • Linninger A.A.
        • Sweetman B.
        • Penn R.
        Normal and hydrocephalic brain dynamics: the role of reduced cerebrospinal fluid reabsorption in ventricular enlargement.
        Ann. Biomed. Eng. 2009; 37: 1434-1447